Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Depression Study Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about Depression Study conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Depression Study Clinical research trials and Depression Study healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as Depression Study. Depression Study Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Depression Study clinical trial. Subjects frequently obtain the most expert healthcare possible for their Depression Study condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.

Home > "D" Clinical Trials Conditions > Depression Study

Depression Study



Depression Study

For Condition: Major Depressive Disorder
Status: Completed
Sponsor(s): Sponsor Name Pending ,
Synopsis: A Placebo Controlled Study Evaluating Efficacy And Safety of Medication In Patients With Major Depressive Disorder (MDD)
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/65 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: (Patients must meet these requirements in order to be eligible for this study.) - Patients meet the diagnosis of Major Depressive Disorder (MDD) Exclusion Criteria: (Patients cannot meet these criteria in order to be eligible for this study.) - Patients with a primary diagnosis other than MDD - Patients with a history of schizophrenia, schizoaffective disorders, seizure disorders or bipolar affective disorder - Patients receiving formal psychotherapy or cognitive/behavioral therapy concurrently or in the 12 weeks prior to screening visit - Patient is actively suicidal - Patients who have a history of migraine headaches
Total Enrollment: 

Location and Contact Information:

Study Site
Austin,  Texas,  78756
United States
 

Study Site
Glen Burnie,  Maryland,  21061
United States
 

Study Site
Lake Jackson,  Texas,  77566
United States
 

Study Site
Denver,  Colorado,  80212
United States
 

Study Site
Jacksonville,  Florida,  32216
United States
 

Study Site
Kenilworth,  New Jersey,  07033
United States
 

Study Site
Nashville,  Tennessee,  37212
United States
 

Study Site
Clementon,  New Jersey,  08021
United States
 

Study Site
Richmond,  Virginia,  23294
United States
 

Study Site
El Centro,  California,  92243
United States
 

Study Site
San Marcos,  California,  92078
United States
 

Study Site
Atlanta,  Georgia,  30308
United States
 

Study Site
Miramichi,  New Brunswick,  E1V 3G5
Canada
 

Study Site
Farmington,  Connecticut,  06030
United States
 

Study Site
Salem,  Oregon,  97309
United States
 

Study Site
Marietta,  Georgia,  30060
United States
 

Study Site
Springfield,  Illinois,  62701
United States
 

Study Site
Markham,  Ontario,  L6B 1A1
Canada
 

Study Site
New Baltimore,  Michigan,  48047
United States
 

Study Site
Toronto,  Ontario,  M5T3A9
Canada
 

Study Site
Okemos,  Michigan,  48864
United States
 

Study Site
New York City,  New York,  10021
United States
 

Study Site
Lake Oswego,  Oregon,  97305
United States
 

Study Site
Irvine,  California,  92618
United States
 

Study Site
Toronto,  Ontario,  M5G 2C4
Canada
 

Study Site
Garden Grove,  California,  92845
United States
 

Study SIte
Houston,  Texas,  77007
United States
 

Study Site
Edmonton,  Alberta,  T6L 5X8
Canada
 

Study Site
Eugene,  Oregon,  97401
United States
 

Study Site
Durham,  North Carolina,  27710
United States
 

Study Site
New York City,  New York,  10024
United States
 

Study Site
Jacksonville,  Florida,  32257
United States
 

Study Site
San Antonio,  Texas,  78229
United States
 

Study Site
Quebec,  ,  G1R 2W8
Canada
 

Study Site
Winnipeg,  Manitoba,  R2H 2A6
Canada
 

Study Site
Libertyville,  Illinois,  60084
United States
 

Study Site
Sherbrooke,  Quebec,  J1H 4J6
Canada
 

Study Site
Las Vegas,  Nevada,  89146
United States
 

Study Site
Beverly Hills,  California,  90210
United States
 

Study Site
Stanford,  California,  94305
United States
 

Study Site
Lexington,  Kentucky,  40509
United States
 

Study Site
New York City,  New York,  10467
United States
 

Study Site
Kelowna,  British Columbia,  V1Y2H4
Canada
 

Study Site
Atlanta,  Georgia,  30329
United States
 

Study Site
Sydney,  Nova Scotia,  B1S2E9
Canada
 


Additional Information:
Study ID Numbers:
  NKD20006; 
Study Start Date: 
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00048204

Other Major Depressive Disorder Studies:
1. A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects with Major Depressive Disorder

2. Efficacy And Safety Of Two Fixed Doses Of DVS-233 SR In Adult Outpatients With Major Depressive Disorder

3. Adult Outpatients with Major Depressive Disorder

4. Brain Regulation of Emotions in People with Depression and Anhedonia

5. Long Term Treatment of Patients with Major Depressive Disorder with an Investigational Compound

Related Studies:

Other Major Depressive Disorder Clinical Trials
Other Colorado Clinical Trials
Other Denver Clinical Trials

Depression Study

Modify your Search

  Other Major Depressive Disorder Clinical Trials
  Other Colorado Clinical Trials
  Other Denver Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103